Ani Pharmaceuticals (ANIP) Assets (2010 - 2026)
Ani Pharmaceuticals (ANIP) posted Assets of $1.4 billion for Q1 2026, down 1.28% sequentially from $1.4 billion in Q4 2025, and up 10.02% YoY from $1.3 billion in Q1 2025.
Ani Pharmaceuticals (ANIP) Assets (2010 - 2026) Analysis & Trends
Ani Pharmaceuticals has reported Assets for 17 years, with the latest figure at $1.4 billion in Q1 2026.
- Quarterly Assets rose 10.02% year-over-year to $1.4 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.4 billion (up 10.02% YoY) and the FY2025 annual result came in at $1.4 billion, up 12.14% from the prior year.
- Assets slipped to $1.4 billion in Q1 2026 per ANIP's latest filing, from $1.4 billion in the prior quarter.
- Over five years, Assets peaked at $1.4 billion in Q4 2025 and troughed at $739.1 million in Q3 2022.
- A 5-year average of $1.0 billion and a median of $914.5 million in 2024 frame the typical range for Assets.
- The widest YoY moves for Assets: up 60.58% in 2022, down 1.49% in 2022.
- Over 5 years, Assets stood at $760.1 million in 2022, then climbed by 18.99% to $904.4 million in 2023, then surged by 42.02% to $1.3 billion in 2024, then grew by 12.14% to $1.4 billion in 2025, then dropped by 1.28% to $1.4 billion in 2026.
- According to Business Quant data, Assets over the past three periods registered $1.4 billion, $1.4 billion, and $1.4 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | 43.71 Bn |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | 39.86 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 15.08 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 98.27 Bn |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | 7.22 Bn |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | 35.04 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 5.36 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 13.56 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | 6.18 Bn |
| 10 | Ani Pharmaceuticals | 1.63 Bn | 1.27 Bn | 165.89 Mn | 1.49 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.49 Bn |
| Mar 31, 2026 | 1.42 Bn |
| Dec 31, 2025 | 1.44 Bn |
| Sep 30, 2025 | 1.41 Bn |
| Jun 30, 2025 | 1.34 Bn |
| Mar 31, 2025 | 1.29 Bn |
| Dec 31, 2024 | 1.28 Bn |
| Sep 30, 2024 | 1.29 Bn |
| Jun 30, 2024 | 920.75 Mn |
| Mar 31, 2024 | 914.52 Mn |
| Dec 31, 2023 | 904.42 Mn |
| Sep 30, 2023 | 889.91 Mn |
| Jun 30, 2023 | 859.34 Mn |
| Mar 31, 2023 | 765.22 Mn |
| Dec 31, 2022 | 760.09 Mn |
| Sep 30, 2022 | 739.11 Mn |
| Jun 30, 2022 | 751.33 Mn |
| Mar 31, 2022 | 744.85 Mn |
| Dec 31, 2021 | 771.60 Mn |
| Sep 30, 2021 | 470.45 Mn |